Accelerated dna vaccine regimen provides protection against crimean-congo hemorrhagic fever virus challenge in a macaque model

HIGHLIGHTS

• who: David W. Hawman from the (UNIVERSITY) have published the article: Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model, in the Journal: (JOURNAL) of 22/07/2022
• what: The authors show that two immunizations of this vaccine platform with both the NP and GPC antigens confer significant protection against CCHFV in infected macaques.
• how: The ELISpot data indicated that cellular immunity in response to pNP and/or pGPC vaccination was low. Serum chemistries were completed on a VetScan VS2 Chemistry Analyzer (Abaxis Union City . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.